Chemkart India Limited (BOM:544442)
215.25
-5.85 (-2.65%)
At close: Nov 16, 2026
Chemkart India Revenue
Chemkart India had revenue of 2.06B INR in the half year ending September 30, 2026, with 81.99% growth. This brings the company's total for the last twelve months to 3.17B, up 64.17% year-over-year. In the fiscal year ending March 31, 2026, Chemkart India had annual revenue of 2.15B with 5.68% growth. That makes Chemkart India the 30,667th largest company in the world by revenue and 2,189th in India.
Revenue (ttm)
3.17B
Revenue Growth
+64.17%
P/S Ratio
0.84
Revenue / Employee
105.83M
Employees
30
Market Cap
2.60B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.15B | 115.51M | 5.68% |
| Mar 31, 2025 | 2.03B | 712.52M | 53.97% |
| Mar 31, 2024 | 1.32B | 6.49M | 0.49% |
| Mar 31, 2023 | 1.31B | 443.97M | 51.04% |
| Mar 31, 2022 | 869.81M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rama Vision | 1.95B |
| Novelix Pharmaceuticals | 1.55B |
| Chandra Bhagat Pharma | 1.17B |
| VijayPD Ceutical | 1.00B |
| Khemani Distributors & Marketing | 987.34M |
| Aptus Pharma | 811.18M |
| Medistep Healthcare | 731.36M |
| Constronics Infra | 454.43M |